MYRIAD GENETICS INC
Public company snapshot, recent ticker-linked headlines, and a path into evidence-backed AI research.
Latest price
$6.35
-4.80%
Yahoo Finance · 10/30/2026
One-year price history
Adjusted daily closes · 252 observations · as of Oct 30, 2026
1 month
+56.4%
3 months
+110.3%
6 months
+32.3%
1 year
-20.1%
Year to date
+3.3%
52-week range
$2.86 – $8.18
Fundamental snapshot
Latest reported period: Jun 30, 2026
Market cap
$607.4M
P/E
-5.4
P/B
2
P/S
0.8
Revenue
$806.6M
Net income
-$112.6M
Diluted EPS
-1.18
Gross margin
68.80%
Net margin
-14.00%
Return on equity
-32.60%
Total debt
$210.5M
Cash
$115.2M
Free cash flow
-$14.2M
Latest eight reported quarters
Reported quarterly values, newest first
| Period | Revenue | Net income | Gross margin | Net margin | Free cash flow |
|---|---|---|---|---|---|
| Jun 30, 2026 | $190.7M | -$43.2M | 66.60% | -22.70% | -$11.5M |
| Mar 31, 2026 | $200.4M | -$34.1M | 68.70% | -17.00% | -$22.2M |
| Dec 31, 2025 | $209.8M | -$7.9M | 70.00% | -3.80% | $4.6M |
| Sep 30, 2025 | $205.7M | -$27.4M | 69.90% | -13.30% | $14.9M |
| Jun 30, 2025 | $213.1M | -$330.5M | 71.20% | -155.10% | -$20.5M |
| Mar 31, 2025 | $195.9M | -$100K | 68.50% | -0.10% | -$24.6M |
| Dec 31, 2024 | $210.6M | -$42.5M | 71.70% | -20.20% | $700K |
| Sep 30, 2024 | $213.3M | -$22.1M | 70.20% | -10.40% | -$5.6M |
Reported figures can reflect company reporting conventions, restatements, or sector-specific accounting. Verify against filings before relying on a valuation comparison.
Recent MYGN news
All market newsNo ticker-linked stories are in the current archive.